Innovative Clinical Trial Designs for Evidence-Based Medicine
Statistical Methods and Healthcare Applications
Inhalt
This book focuses on current research and methodologies developed for re-engineering cancer clinical trials and also for "hot" areas in drug development trials such as adaptive design, seamless Phase 2-3 trials, and personalized medicine using biomarkers. Background statistical methodology is summarized in the Appendix.
Bibliografische Angaben
Januar 2026, ca. 300 Seiten, Chapman & Hall/CRC Biostatistics Series, Englisch
Taylor and Francis
978-1-4665-1486-7